How PBMs Help Manage Stop Loss Risk: What Brokers and Employers Need to Know
Rising stop loss premiums are putting new pressure on self funded employers and the brokers who advise them. Many plans are seeing increased renewal rates, driven in part by specialty...
Foundayo is approved for use in combination with a reduced-calorie diet and increased physical activity to reduce excess body weight and maintain weight reduction long term in adults…
Manufacturer Novo Nordisk received FDA approval for oral semiglutide on 12/22/2025. These new indications for Wegovy tablets are for chronic weight management and to reduce the risk of major cardiovascular events in adults with obesity or overweight.
At ClearScript, we are committed to keeping you informed and prepared for the evolving landscape of Pharmacy Benefit Management (PBM). This update highlights key regulatory changes, industry updates, and ClearScript’s proactive strategies.
If you’re managing pharmacy benefits in 2026, you’re likely facing rising costs, new therapies, and tough decisions. So how do you stay ahead? It starts with understanding what drives trend and how to manage it with confidence.
You Deserve More Than Reporting — And That’s Exactly What We Deliver
How ClearScript Partners With You to Improve Plan Performance, Not Just Measure It. At ClearScript, we’re proud to serve as more than just your pharmacy benefit manager. We’re your partner in navigating a complex and constantly evolving pharmacy landscape. And while robust reporting is a key part of our service, it’s only the beginning.